Synergistic epigenetic reactivation of estrogen receptor-α (ERα) by combined green tea polyphenol and histone deacetylase inhibitor in ERα-negative breast cancer cells

Molecular Cancer

Volumn 9, Issue , 2010, Pages

  Li, Yuanyuan ^a   Yuan, Yih Ying ^a   Meeran, Syed M ^a   Tollefsbol, Trygve O ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA METHYLTRANSFERASE 1; EPIGALLOCATECHIN GALLATE; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; HISTONE DEACETYLASE 5; PROTEIN P130; RETINOBLASTOMA PROTEIN; TAMOXIFEN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E2F4; TRANSCRIPTION FACTOR SUV39H1; TRICHOSTATIN A; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; CATECHIN; DRUG DERIVATIVE; HISTONE DEACETYLASE INHIBITOR; HYDROXAMIC ACID;

ACETYLATION; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CHEMOSENSITIZATION; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMATIN STRUCTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENTIATION; EPIGENETICS; METHYLATION; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; TEA; TRANSCRIPTION INITIATION; BREAST TUMOR; CELL SURVIVAL; CHROMATIN IMMUNOPRECIPITATION; DNA METHYLATION; DRUG EFFECT; FEMALE; GENETICS; HUMAN; METABOLISM; POLYMERASE CHAIN REACTION; TUMOR CELL LINE; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; BREAST NEOPLASMS; CATECHIN; CELL LINE, TUMOR; CELL SURVIVAL; CHROMATIN IMMUNOPRECIPITATION; DNA METHYLATION; DRUG SYNERGISM; ESTROGEN RECEPTOR ALPHA; FEMALE; HISTONE DEACETYLASE INHIBITORS; HUMANS; HYDROXAMIC ACIDS; POLYMERASE CHAIN REACTION; PROMOTER REGIONS, GENETIC; TAMOXIFEN;

EID: 77957784810     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-9-274     Document Type: Article

References (34)

1. Perou CM, Sørlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lønning PE, Børresen-Dale AL, Brown PO, Botstein D. Molecular portraits of human breast tumours. Nature 2000, 406:747-752. 10.1038/35021093, 10963602.
2. Klinge C. Estrogen receptor interaction with estrogen response elements. Nucleic Acids Res 2001, 29:2905-2919. 10.1093/nar/29.14.2905, 55815, 11452016.
3. McDonnell D, Norris J. Connections and regulation of the human estrogen receptor. Science 2002, 296:1642-1644. 10.1126/science.1071884, 12040178.
4. Gadducci A, Biglia N, Sismondi P, Genazzani A. Breast cancer and sex steroids: critical review of epidemiological, experimental and clinical investigations on etiopathogenesis, chemoprevention and endocrine treatment of breast cancer. Gynecol Endocrinol 2005, 20:343-360. 10.1080/09513590500128492, 16019385.
5. Roodi N, Bailey L, Kao W, Verrier C, Yee C, Dupont W, Parl F. Estrogen receptor gene analysis in estrogen receptor-positive and receptor-negative primary breast cancer. J Natl Cancer Inst 1995, 87:446-451. 10.1093/jnci/87.6.446, 7861463.
6. Lapidus R, Nass S, Butash K, Parl F, Weitzman S, Graff J, Herman J, Davidson N. Mapping of ER gene CpG island methylation-specific polymerase chain reaction. Cancer Res 1998, 58:2515-2519.
7. Ottaviano Y, Issa J, Parl F, Smith H, Baylin S, Davidson N. Methylation of the estrogen receptor gene CpG island marks loss of estrogen receptor expression in human breast cancer cells. Cancer Res 1994, 54:2552-2555.
8. Yang X, Phillips D, Ferguson A, Nelson W, Herman J, Davidson N. Synergistic activation of functional estrogen receptor (ER)-alpha by DNA methyltransferase and histone deacetylase inhibition in human ER-alpha-negative breast cancer cells. Cancer Res 2001, 61:7025-7029.
9. Yang X, Ferguson A, Nass S, Phillips D, Butash K, Wang S, Herman J, Davidson N. Transcriptional activation of estrogen receptor alpha in human breast cancer cells by histone deacetylase inhibition. Cancer Res 2000, 60:6890-6894.
10. Bovenzi V, Momparler R. Antineoplastic action of 5-aza-2'-deoxycytidine and histone deacetylase inhibitor and their effect on the expression of retinoic acid receptor beta and estrogen receptor alpha genes in breast carcinoma cells. Cancer Chemother Pharmacol 2001, 48:71-76. 10.1007/s002800100294, 11488527.
11. Jang E, Lim S, Lee E, Jeong G, Kim T, Bang Y, Lee J. The histone deacetylase inhibitor trichostatin A sensitizes estrogen receptor alpha-negative breast cancer cells to tamoxifen. Oncogene 2004, 23:1724-1736. 10.1038/sj.onc.1207315, 14676837.
12. Sharma D, Saxena N, Davidson N, Vertino P. Restoration of tamoxifen sensitivity in estrogen receptor-negative breast cancer cells: tamoxifen-bound reactivated ER recruits distinctive corepressor complexes. Cancer Res 2006, 66:6370-6378. 10.1158/0008-5472.CAN-06-0402, 2925469, 16778215.
13. Yang C, Landau J, Huang M, Newmark H. Inhibition of carcinogenesis by dietary polyphenolic compounds. Annu Rev Nutr 2001, 21:381-406. 10.1146/annurev.nutr.21.1.381, 11375442.
14. Thangapazham R, Singh A, Sharma A, Warren J, Gaddipati J, Maheshwari R. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo. Cancer Lett 2007, 245:232-241. 10.1016/j.canlet.2006.01.027, 16519995.
15. Belguise K, Guo S, Sonenshein G. Activation of FOXO3a by the green tea polyphenol epigallocatechin-3-gallate induces estrogen receptor alpha expression reversing invasive phenotype of breast cancer cells. Cancer Res 2007, 67:5763-5770. 10.1158/0008-5472.CAN-06-4327, 17575143.
16. Chisholm K, Bray B, Rosengren R. Tamoxifen and epigallocatechin gallate are synergistically cytotoxic to MDA-MB-231 human breast cancer cells. Anticancer Drugs 2004, 15:889-897. 10.1097/00001813-200410000-00010, 15457130.
17. Berletch J, Liu C, Love W, Andrews L, Katiyar S, Tollefsbol T. Epigenetic and genetic mechanisms contribute to telomerase inhibition by EGCG. J Cell Biochem 2008, 103:509-519. 10.1002/jcb.21417, 2435482, 17570133.
18. Fang M, Wang Y, Ai N, Hou Z, Sun Y, Lu H, Welsh W, Yang C. Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. Cancer Res 2003, 63:7563-7570.
19. Fang M, Chen D, Yang C. Dietary polyphenols may affect DNA methylation. J Nutr 2007, 137:223S-228S.
20. Li Y, Liu L, Andrews L, Tollefsbol T. Genistein depletes telomerase activity through cross-talk between genetic and epigenetic mechanisms. Int J Cancer 2009, 125:286-296. 10.1002/ijc.24398, 19358274.
21. Li Y, Liu L, Tollefsbol T. Glucose restriction can extend normal cell lifespan and impair precancerous cell growth through epigenetic control of hTERT and p16 expression. FASEB J 2010, 24:1442-1453. 10.1096/fj.09-149328, 20019239.
22. Goodin M, Fertuck K, Zacharewski T, Rosengren R. Estrogen receptor-mediated actions of polyphenolic catechins in vivo and in vitro. Toxicol Sci 2002, 69:354-361. 10.1093/toxsci/69.2.354, 12377984.
23. Clarke R, Liu M, Bouker K, Gu Z, Lee R, Zhu Y, Skaar T, Gomez B, O'Brien K, Wang Y, Hilakivi-Clarke L. Antiestrogen resistance in breast cancer and the role of estrogen receptor signaling. Oncogene 2003, 22:7316-7339. 10.1038/sj.onc.1206937, 14576841.
24. Mandlekar S, Kong A. Mechanisms of tamoxifen-induced apoptosis. Apoptosis 2001, 6:469-477. 10.1023/A:1012437607881, 11595837.
25. Jenuwein T, Allis C. Translating the histone code. Science 2001, 293:1074-1080. 10.1126/science.1063127, 11498575.
26. Laird P, Jaenisch R. The role of DNA methylation in cancer genetic and epigenetics. Annu Rev Genet 1996, 30:441-464. 10.1146/annurev.genet.30.1.441, 8982461.
27. Grunstein M. Histone acetylation in chromatin structure and transcription. Nature 1997, 389:349-352. 10.1038/38664, 9311776.
28. Vaute O, Nicolas E, Vandel L, Trouche D. Functional and physical interaction between the histone methyl transferase Suv39H1 and histone deacetylases. Nucleic Acids Res 2002, 30:475-481. 10.1093/nar/30.2.475, 99834, 11788710.
29. Macaluso M, Cinti C, Russo G, Russo A, Giordano A. pRb2/p130-E2F4/5-HDAC1-SUV39H1-p300 and pRb2/p130-E2F4/5-HDAC1-SUV39H1-DNMT1 multimolecular complexes mediate the transcription of estrogen receptor-alpha in breast cancer. Oncogene 2003, 22:3511-3517. 10.1038/sj.onc.1206578, 12789259.
30. Bushman J. Green tea and cancer in humans: a review of the literature. Nutr Cancer 1998, 31:151-159. 10.1080/01635589809514697, 9795966.
31. Nakachi K, Suemasu K, Suga K, Takeo T, Imai K, Higashi Y. Influence of drinking green tea on breast cancer malignancy among Japanese patients. Jpn J Cancer Res 1998, 89:254-261.
32. Li Y, Tollefsbol T. Impact on DNA methylation in cancer prevention and therapy by bioactive dietary components. Curr Med Chem 2010, 17:2141-2151. 10.2174/092986710791299966, 2904405, 20423306.
33. Vasanthi H, Mukherjee S, Das D. Potential health benefits of broccoli - a chemico-biological overview. Mini Rev Med Chem 2009, 9:749-759. 10.2174/138955709788452685, 19519500.
34. Juge N, Mithen R, Traka M. Molecular basis for chemoprevention by sulforaphane: a comprehensive review. Cell Mol Life Sci 2007, 64:1105-1127. 10.1007/s00018-007-6484-5, 17396224.